1,364
Views
4
CrossRef citations to date
0
Altmetric
Articles

Sarcopenia as a Determinant of the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Meta-Analysis

, , &
Pages 685-695 | Received 07 Sep 2022, Accepted 28 Nov 2022, Published online: 19 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jingjing Li & Xuanfu Xu. (2023) Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview. International Journal of General Medicine 16, pages 1527-1540.
Read now

Articles from other publishers (3)

Chunxun Liu, Haoran Zhao, Rujia Zhang, Zuoming Guo, Peng Wang & Zhaowei Qu. (2023) Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors. Oncology Letters 26:4.
Crossref
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, Alberto G. Agostara, Sara Oresti, Annalisa Zeppellini, Laura Giannetta, Giulio Cerea, Diego Signorelli, Salvatore Siena & Andrea Sartore-Bianchi. (2023) Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity. Cancer Research 83:14, pages 2283-2296.
Crossref
Marta Tenuta, Carla Pandozzi, Francesca Sciarra, Federica Campolo, Alain J. Gelibter, Grazia Sirgiovanni, Enrico Cortesi, Andrea Lenzi, Andrea M. Isidori, Emilia Sbardella & Mary Anna Venneri. (2023) Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia. Cancers 15:14, pages 3592.
Crossref